CANADA
Canadian Thoracic Society
REVISED December 2021 – CTS Information and Guidance for Respiratory Health Care Professionals on COVID-19 Vaccination
NEW December 2021 – CTS-AMMI Canada joint statement promoting dual vaccination against influenza and COVID-19
Biologic Therapy and the COVID-19 vaccine – Advice for individuals with asthma – June 30, 2021
VIDEO – What you need to know about the delta variant presented by Dr. Samir Gupta, June 29, 2021
VIDEO – Which COVID-19 vaccine is better? presented by Dr. Samir Gupta – April 2, 2021
Recording of Vaccine Hesitancy webinar delivered by Dr. Kim Lavoie on Dec 17, 2020
Respiratory Roundtable Joint Statement on the prioritization of Canadians with lung disease in COVID-19 vaccination rollout
AMMI Canada Educational Webinars on COVID-19 vaccines
Canadian Institutes of Health Research (CIHR)
Presentations:
Long COVID: Emerging Research and Gaps in Canada
GLOPID-R – Long Covid
State of Knowledge, Emerging Research Needs & Canadian Research Landscape for Post-COVID-19 conditions
Recommended Resources
Canadian Medical Association (CFPC & RCPSC)
Questions and answers on COVID-19: https://www.covidquestions.ca
Canadian Paediatric Society
COVID-19 vaccine for children 5 to 11 years of age – Nov 23, 2021
Clinical guidance for youth with myocarditis and pericarditis following mRNA COVID-19 Vaccination – Sept 2021
Position Statement: COVID-19 vaccine for children – May 21, 2021
Online CME module re: Our best shot at beating COVID-19: Overcoming vaccine hesitancy in 2021
It is accredited for specialists (and a MAINPRO application is in the works). The module covers all ages.
CANVAX
REGISTER – Webinar: NACI Recommendations on COVID-19 Vaccine Interchangeability
June 21, 2021 – 2:00 PM – 3:00 PM Eastern Time
COVID-19 Vaccine Questions and Answers for Healthcare Providers
CoVaRR-Net – Coronavirus Variants Rapid Response Network (CoVaRR-Net) is a network of interdisciplinary researchers from institutions across the country created to assist in the Government of Canada’s overall strategy to address the potential threat of emerging SARS-CoV-2 variants.
National Collaborating Centre for Infectious Diseases
Recommendations of the National Advisory Committee on Immunization (NACI) on Extended Dose Intervals for COVID-19 Vaccines
COVID-19 Vaccines Planning for Immunization Clinics – March 1, 2021
COVID-19 Vaccines Foundational Webinar – Feb 23, 2021
COVID-19 Vaccines – Allergies and LDV Syringe Discussion – Feb 10, 2021
National Institute of Ageing
COVID-19 Visit Risk Calculator
Public Health Agency of Canada
NACI Recommendations on Extended Dose Intervals for COVID-19 Vaccines webinar on May 5, 2021
Click here for the recording
Infobulletin on VITT for health care providers – April 13, 2021
Respiplus
Addressing Patient Hesitancy: https://youtu.be/6OqQfuwDhTM – August 2021
Getting Ready for “Back to…Normal”: https://youtu.be/TBeGyjVqS-Q – May 2021
Think Research/MDBriefcase
Managing Vaccine Hesitancy – Accredited Program – March 25, 2021
Think Research launched an educational hub hosted by MDBriefcase which includes an accredited Vaccine Hesitancy program designed for primary care physicians and other supporting clinicians to help improve vaccine confidence in patients.
- Likelihood of Transmission of COVID-19 infection after COVID-19 Vaccination – published March 23, 2021
- Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations – published Feb 26, 2021
- AstraZeneca AZD1222 US Phase III primary analysis confirms safety and efficacy published March 25, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine – published April 22, 2021
- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine – published May 13, 2021
- Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial – published March 30, 2021
- Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa – published on Feb 12, 2021
- Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers – published on Feb 11, 2021
- T cell response to SARS-CoV-2 infection in humans: A systematic review – published on January 25, 2021
- SARS-CoV-2 is associated with high viral loads in asymptomatic and recently symptomatic healthcare workers – published on March 18, 2021
- Single dose of a mRNA SARS-CoV-2 vaccine is associated with lower nasopharyngeal viral load among nursing home residents with asymptomatic COVID-19 – published on March 26, 2021
- Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine – published on March 29, 2021
- Effect of vaccination on transmission of COVID-19: an observational study in healthcare workers and their households – published on March 21, 2021
- Impact of vaccination on household transmission of SARS-COV-2 in England – published April 13, 2021
- Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination – published April 1, 2021
- Modelling the impact of extending dose intervals for COVID-19 vaccines in Canada – published April 10, 2021
- Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients – published May 5, 2021
INTERNATIONAL
COVID-NMA Initiative
COVID-19 Vaccine Effectiveness – Randomized Evidence
Centers for Disease Control and Prevention
COVID-19 Vaccination Communication Toolkit
Public Health England
COVID-19 vaccination: information for healthcare practitioners
World Health Organization
COVID-19 variants & vaccines